Clinical Trial Update: Endothelial Protection in Convalescent COVID-19 Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating endothelial protection in convalescent COVID-19 patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Inflammation
• Thrombosis

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: Endothelial Dysfunction, Inflammation | Phase 4 | Status: TERMINATED